The global Corticosteroids API market size is predicted to grow from US$ 2498 million in 2025 to US$ 3612 million in 2031; it is expected to grow at a CAGR of 6.3% from 2025 to 2031.
Corticosteroids Active Pharmaceutical Ingredients (APIs) are key raw materials used in the production of corticosteroid medications, which are widely utilized for their anti-inflammatory, immunosuppressive, and anti-allergic properties. These APIs include compounds such as hydrocortisone, prednisolone, dexamethasone, and betamethasone, which are essential in the treatment of conditions like asthma, rheumatoid arthritis, skin disorders, and autoimmune diseases. The production of corticosteroid APIs involves complex chemical synthesis and stringent quality control to ensure high purity, efficacy, and compliance with regulatory standards such as those set by the US FDA, EU EMA, and China NMPA. As demand for corticosteroid-based treatments continues to grow, particularly in dermatology, respiratory diseases, and organ transplantation, the corticosteroid API market remains a crucial segment within the pharmaceutical industry.
The corticosteroids API market has maintained stable growth in recent years, driven primarily by the pharmaceutical industry's demand. As a key component widely used in the treatment of inflammation, immunosuppression, dermatological conditions, and respiratory diseases, corticosteroids APIs continue to be in demand globally. Factors such as an aging population, rising prevalence of chronic diseases, and improvements in healthcare systems contribute to the increasing need for high-quality APIs. Additionally, the expansion of the generic drug industry has fueled market growth, particularly in emerging economies where policy support and the enhancement of local pharmaceutical capabilities are strengthening demand.
Looking ahead, the corticosteroids API market is expected to follow several key trends. Firstly, stricter environmental regulations are driving the need for greener and more compliant manufacturing processes, pushing companies to invest in R&D to reduce emissions and improve production efficiency. Secondly, as market competition intensifies, some high-end corticosteroid products will shift toward high-value generics following patent expirations, enabling differentiation strategies. Additionally, supply chain localization is becoming more prominent, with certain countries and regions strengthening their domestic API supply capabilities to reduce import dependency, impacting the global market structure. Furthermore, advancements in biotechnology may introduce new synthetic pathways and alternative therapies that could pose a challenge to the traditional corticosteroids API market.
Key growth drivers include rising medical demand, expansion of the global pharmaceutical industry, and policy support, particularly in emerging markets where governments encourage local production and offer tax incentives. Additionally, advancements in production technology, formulation innovations, and new indications are creating new growth opportunities. However, the industry faces challenges such as fluctuations in raw material prices, rising environmental compliance costs, and intense competition among leading manufacturers. Stricter global regulatory policies impose higher compliance requirements, potentially driving some companies out of the market. Moreover, increasing competition in the generics sector is putting pricing pressure on APIs, affecting overall profitability.
The 鈥淐orticosteroids API Industry Forecast鈥� looks at past sales and reviews total world Corticosteroids API sales in 2024, providing a comprehensive analysis by region and market sector of projected Corticosteroids API sales for 2025 through 2031. With Corticosteroids API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Corticosteroids API industry.
This Insight Report provides a comprehensive analysis of the global Corticosteroids API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Corticosteroids API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Corticosteroids API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Corticosteroids API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Corticosteroids API.
This report presents a comprehensive overview, market shares, and growth opportunities of Corticosteroids API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Prednisone Series
Dexamethasone Series
Betamethasone Series
Hydrocortisone Series
Others
Segmentation by Application:
Injectable Drugs
Oral Drugs
Topical Drugs
Inhaled Drugs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pfizer CentreOne
EUROAPI
GlaxoSmithKline
Teva Pharmaceutical Industries
Hovione
Axplora
Steroid SpA
Avik Pharmaceutical
Anuh Pharma
Symbiotec Pharmalab
Sun Pharmaceutical
Cipla
Wellona Pharma
Tianjin Tianyao Pharmaceuticals
Zhejiang Xianju Pharmaceutical
Guangdong VTR BioTech
Zhejiang Xianju Xianle Pharmaceutical
Tianjin Pacific Pharmaceutical
Shandong Xinhua Pharmaceutica Group
Jiangsu Lianhuan Pharmaceutical
Shanghai New Hualian Pharmaceutical
Shandong Taihua Biotech
Shandong Sito Bio-technology
Zhejiang Xianju Junye Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Corticosteroids API market?
What factors are driving Corticosteroids API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Corticosteroids API market opportunities vary by end market size?
How does Corticosteroids API break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Corticosteroids API Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Corticosteroids API by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Corticosteroids API by Country/Region, 2020, 2024 & 2031
2.2 Corticosteroids API Segment by Type
2.2.1 Prednisone Series
2.2.2 Dexamethasone Series
2.2.3 Betamethasone Series
2.2.4 Hydrocortisone Series
2.2.5 Others
2.3 Corticosteroids API Sales by Type
2.3.1 Global Corticosteroids API Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Corticosteroids API Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Corticosteroids API Sale Price by Type (2020-2025)
2.4 Corticosteroids API Segment by Application
2.4.1 Injectable Drugs
2.4.2 Oral Drugs
2.4.3 Topical Drugs
2.4.4 Inhaled Drugs
2.5 Corticosteroids API Sales by Application
2.5.1 Global Corticosteroids API Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Corticosteroids API Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Corticosteroids API Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Corticosteroids API Breakdown Data by Company
3.1.1 Global Corticosteroids API Annual Sales by Company (2020-2025)
3.1.2 Global Corticosteroids API Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Corticosteroids API Annual Revenue by Company (2020-2025)
3.2.1 Global Corticosteroids API Revenue by Company (2020-2025)
3.2.2 Global Corticosteroids API Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Corticosteroids API Sale Price by Company
3.4 Key Manufacturers Corticosteroids API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Corticosteroids API Product Location Distribution
3.4.2 Players Corticosteroids API Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Corticosteroids API by Geographic Region
4.1 World Historic Corticosteroids API 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Corticosteroids API Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Corticosteroids API Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Corticosteroids API 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Corticosteroids API Annual Sales by Country/Region (2020-2025)
4.2.2 Global Corticosteroids API Annual Revenue by Country/Region (2020-2025)
4.3 Americas Corticosteroids API Sales Growth
4.4 APAC Corticosteroids API Sales Growth
4.5 Europe Corticosteroids API Sales Growth
4.6 Middle East & Africa Corticosteroids API Sales Growth
5 Americas
5.1 Americas Corticosteroids API Sales by Country
5.1.1 Americas Corticosteroids API Sales by Country (2020-2025)
5.1.2 Americas Corticosteroids API Revenue by Country (2020-2025)
5.2 Americas Corticosteroids API Sales by Type (2020-2025)
5.3 Americas Corticosteroids API Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Corticosteroids API Sales by Region
6.1.1 APAC Corticosteroids API Sales by Region (2020-2025)
6.1.2 APAC Corticosteroids API Revenue by Region (2020-2025)
6.2 APAC Corticosteroids API Sales by Type (2020-2025)
6.3 APAC Corticosteroids API Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Corticosteroids API by Country
7.1.1 Europe Corticosteroids API Sales by Country (2020-2025)
7.1.2 Europe Corticosteroids API Revenue by Country (2020-2025)
7.2 Europe Corticosteroids API Sales by Type (2020-2025)
7.3 Europe Corticosteroids API Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Corticosteroids API by Country
8.1.1 Middle East & Africa Corticosteroids API Sales by Country (2020-2025)
8.1.2 Middle East & Africa Corticosteroids API Revenue by Country (2020-2025)
8.2 Middle East & Africa Corticosteroids API Sales by Type (2020-2025)
8.3 Middle East & Africa Corticosteroids API Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Corticosteroids API
10.3 Manufacturing Process Analysis of Corticosteroids API
10.4 Industry Chain Structure of Corticosteroids API
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Corticosteroids API Distributors
11.3 Corticosteroids API Customer
12 World Forecast Review for Corticosteroids API by Geographic Region
12.1 Global Corticosteroids API 麻豆原创 Size Forecast by Region
12.1.1 Global Corticosteroids API Forecast by Region (2026-2031)
12.1.2 Global Corticosteroids API Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Corticosteroids API Forecast by Type (2026-2031)
12.7 Global Corticosteroids API Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Pfizer CentreOne
13.1.1 Pfizer CentreOne Company Information
13.1.2 Pfizer CentreOne Corticosteroids API Product Portfolios and Specifications
13.1.3 Pfizer CentreOne Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer CentreOne Main Business Overview
13.1.5 Pfizer CentreOne Latest Developments
13.2 EUROAPI
13.2.1 EUROAPI Company Information
13.2.2 EUROAPI Corticosteroids API Product Portfolios and Specifications
13.2.3 EUROAPI Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 EUROAPI Main Business Overview
13.2.5 EUROAPI Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Corticosteroids API Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 Teva Pharmaceutical Industries
13.4.1 Teva Pharmaceutical Industries Company Information
13.4.2 Teva Pharmaceutical Industries Corticosteroids API Product Portfolios and Specifications
13.4.3 Teva Pharmaceutical Industries Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Teva Pharmaceutical Industries Main Business Overview
13.4.5 Teva Pharmaceutical Industries Latest Developments
13.5 Hovione
13.5.1 Hovione Company Information
13.5.2 Hovione Corticosteroids API Product Portfolios and Specifications
13.5.3 Hovione Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Hovione Main Business Overview
13.5.5 Hovione Latest Developments
13.6 Axplora
13.6.1 Axplora Company Information
13.6.2 Axplora Corticosteroids API Product Portfolios and Specifications
13.6.3 Axplora Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Axplora Main Business Overview
13.6.5 Axplora Latest Developments
13.7 Steroid SpA
13.7.1 Steroid SpA Company Information
13.7.2 Steroid SpA Corticosteroids API Product Portfolios and Specifications
13.7.3 Steroid SpA Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Steroid SpA Main Business Overview
13.7.5 Steroid SpA Latest Developments
13.8 Avik Pharmaceutical
13.8.1 Avik Pharmaceutical Company Information
13.8.2 Avik Pharmaceutical Corticosteroids API Product Portfolios and Specifications
13.8.3 Avik Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Avik Pharmaceutical Main Business Overview
13.8.5 Avik Pharmaceutical Latest Developments
13.9 Anuh Pharma
13.9.1 Anuh Pharma Company Information
13.9.2 Anuh Pharma Corticosteroids API Product Portfolios and Specifications
13.9.3 Anuh Pharma Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Anuh Pharma Main Business Overview
13.9.5 Anuh Pharma Latest Developments
13.10 Symbiotec Pharmalab
13.10.1 Symbiotec Pharmalab Company Information
13.10.2 Symbiotec Pharmalab Corticosteroids API Product Portfolios and Specifications
13.10.3 Symbiotec Pharmalab Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Symbiotec Pharmalab Main Business Overview
13.10.5 Symbiotec Pharmalab Latest Developments
13.11 Sun Pharmaceutical
13.11.1 Sun Pharmaceutical Company Information
13.11.2 Sun Pharmaceutical Corticosteroids API Product Portfolios and Specifications
13.11.3 Sun Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Sun Pharmaceutical Main Business Overview
13.11.5 Sun Pharmaceutical Latest Developments
13.12 Cipla
13.12.1 Cipla Company Information
13.12.2 Cipla Corticosteroids API Product Portfolios and Specifications
13.12.3 Cipla Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Cipla Main Business Overview
13.12.5 Cipla Latest Developments
13.13 Wellona Pharma
13.13.1 Wellona Pharma Company Information
13.13.2 Wellona Pharma Corticosteroids API Product Portfolios and Specifications
13.13.3 Wellona Pharma Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Wellona Pharma Main Business Overview
13.13.5 Wellona Pharma Latest Developments
13.14 Tianjin Tianyao Pharmaceuticals
13.14.1 Tianjin Tianyao Pharmaceuticals Company Information
13.14.2 Tianjin Tianyao Pharmaceuticals Corticosteroids API Product Portfolios and Specifications
13.14.3 Tianjin Tianyao Pharmaceuticals Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Tianjin Tianyao Pharmaceuticals Main Business Overview
13.14.5 Tianjin Tianyao Pharmaceuticals Latest Developments
13.15 Zhejiang Xianju Pharmaceutical
13.15.1 Zhejiang Xianju Pharmaceutical Company Information
13.15.2 Zhejiang Xianju Pharmaceutical Corticosteroids API Product Portfolios and Specifications
13.15.3 Zhejiang Xianju Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Zhejiang Xianju Pharmaceutical Main Business Overview
13.15.5 Zhejiang Xianju Pharmaceutical Latest Developments
13.16 Guangdong VTR BioTech
13.16.1 Guangdong VTR BioTech Company Information
13.16.2 Guangdong VTR BioTech Corticosteroids API Product Portfolios and Specifications
13.16.3 Guangdong VTR BioTech Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Guangdong VTR BioTech Main Business Overview
13.16.5 Guangdong VTR BioTech Latest Developments
13.17 Zhejiang Xianju Xianle Pharmaceutical
13.17.1 Zhejiang Xianju Xianle Pharmaceutical Company Information
13.17.2 Zhejiang Xianju Xianle Pharmaceutical Corticosteroids API Product Portfolios and Specifications
13.17.3 Zhejiang Xianju Xianle Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Zhejiang Xianju Xianle Pharmaceutical Main Business Overview
13.17.5 Zhejiang Xianju Xianle Pharmaceutical Latest Developments
13.18 Tianjin Pacific Pharmaceutical
13.18.1 Tianjin Pacific Pharmaceutical Company Information
13.18.2 Tianjin Pacific Pharmaceutical Corticosteroids API Product Portfolios and Specifications
13.18.3 Tianjin Pacific Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Tianjin Pacific Pharmaceutical Main Business Overview
13.18.5 Tianjin Pacific Pharmaceutical Latest Developments
13.19 Shandong Xinhua Pharmaceutica Group
13.19.1 Shandong Xinhua Pharmaceutica Group Company Information
13.19.2 Shandong Xinhua Pharmaceutica Group Corticosteroids API Product Portfolios and Specifications
13.19.3 Shandong Xinhua Pharmaceutica Group Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Shandong Xinhua Pharmaceutica Group Main Business Overview
13.19.5 Shandong Xinhua Pharmaceutica Group Latest Developments
13.20 Jiangsu Lianhuan Pharmaceutical
13.20.1 Jiangsu Lianhuan Pharmaceutical Company Information
13.20.2 Jiangsu Lianhuan Pharmaceutical Corticosteroids API Product Portfolios and Specifications
13.20.3 Jiangsu Lianhuan Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Jiangsu Lianhuan Pharmaceutical Main Business Overview
13.20.5 Jiangsu Lianhuan Pharmaceutical Latest Developments
13.21 Shanghai New Hualian Pharmaceutical
13.21.1 Shanghai New Hualian Pharmaceutical Company Information
13.21.2 Shanghai New Hualian Pharmaceutical Corticosteroids API Product Portfolios and Specifications
13.21.3 Shanghai New Hualian Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Shanghai New Hualian Pharmaceutical Main Business Overview
13.21.5 Shanghai New Hualian Pharmaceutical Latest Developments
13.22 Shandong Taihua Biotech
13.22.1 Shandong Taihua Biotech Company Information
13.22.2 Shandong Taihua Biotech Corticosteroids API Product Portfolios and Specifications
13.22.3 Shandong Taihua Biotech Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 Shandong Taihua Biotech Main Business Overview
13.22.5 Shandong Taihua Biotech Latest Developments
13.23 Shandong Sito Bio-technology
13.23.1 Shandong Sito Bio-technology Company Information
13.23.2 Shandong Sito Bio-technology Corticosteroids API Product Portfolios and Specifications
13.23.3 Shandong Sito Bio-technology Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 Shandong Sito Bio-technology Main Business Overview
13.23.5 Shandong Sito Bio-technology Latest Developments
13.24 Zhejiang Xianju Junye Pharmaceutical
13.24.1 Zhejiang Xianju Junye Pharmaceutical Company Information
13.24.2 Zhejiang Xianju Junye Pharmaceutical Corticosteroids API Product Portfolios and Specifications
13.24.3 Zhejiang Xianju Junye Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
13.24.4 Zhejiang Xianju Junye Pharmaceutical Main Business Overview
13.24.5 Zhejiang Xianju Junye Pharmaceutical Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
